The prescription drug industry is facing an increasingly crowded market with counterfeit drugs.
The FDA is facing a shortage of prescription drugs and manufacturers are working to combat the problem.
The Drug Enforcement Administration says it has identified 5.4 million counterfeit drugs in the United States, and there have been more than 10,000 drug overdose deaths attributed to them in 2016.
The problem is being worsened by rising drug prices, which are set to reach $20,000 per pill by 2021.
Many prescription drugs are made by the same companies that manufacture them.
This means that the counterfeits are the same ones that you’ll see on the shelf at the pharmacy.
According to a study published in the journal Drug Testing, the average pharmacy chain’s inventory of counterfeit drugs had increased by 50 percent between 2011 and 2016.
This was in addition to the $4 billion in frauds reported in 2017 alone.
Many of the counterfeit drugs are manufactured in China, and they’re often more potent and have a higher concentration of fentanyl, the main ingredient in heroin.
This increases the risk of overdose and death.
According the report, the counterfeit drug threat is more acute in urban areas, where drug cartels are making more money.
“It’s a very expensive industry and if they want to keep making more, they’ll be making more,” said James R. Ruppert, the DEA’s assistant administrator for drug policy.
Ruppert said that there are currently about 3,600 federal labs in the U.S. that test for drugs.
That number will likely grow to 10,200 by 2021, and another 2,600 by 2024.
In addition, there are approximately 6,200 drug-sniffing dogs on the force, which help track down drugs that may be in the wrong hands.
Rooftop pharmacies are also increasingly being targeted by these counterfeit drugs, because they’re located in the most densely populated areas of the country.
Some of the top pharmacy chains have taken steps to limit the volume of drugs that can be sold in their stores.
The drug industry has been trying to reduce the number of counterfeit medicines it makes and to identify and track down the culprits.
However, there’s a huge gap between what the FDA is doing and what states are doing.
The FDA has already put in place a number of initiatives aimed at stopping drug diversion. “
In fact, the drugs have gotten worse, and it’s gotten worse in the states, so it’s a challenge.”
The FDA has already put in place a number of initiatives aimed at stopping drug diversion.
The Drug Enforcement Agency has launched an investigation into the problem of drug diversion, and the agency recently released a guide on how to protect yourself and your family from counterfeit medicines.
But many people are hesitant to take action because they don’t know how.
“They’re really worried that if I say I’m not going to do anything, they’re going to say, ‘You’re not doing anything,'” said Sarah Anderson, a former pharmacy technician from Georgia who’s currently an employee at a pharmacy chain.
Anderson said she believes many people just want to avoid the hassle of going to the pharmacy, and she’s not entirely wrong.
“I think there’s so much anxiety about that, but I think a lot of people are really scared,” she said.
“But you have to understand, if you’re not worried, you don’t need to go to the store,” she added.
“I think the main thing that’s going to help is just to be patient, and not go and get caught up in this.”